Aviance Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$458K Sell
5,287
-30
-0.6% -$2.87K 0.05% 251
2025
Q4
$511K Sell
5,317
-404
-7% -$39.2K 0.06% 232
2025
Q3
$545K Buy
5,721
+339
+6% +$31.2K 0.06% 223
2025
Q2
$469K Buy
5,382
+858
+19% +$72.8K 0.06% 229
2025
Q1
$407K Buy
4,524
+148
+3% +$13.2K 0.06% 237
2024
Q4
$350K Buy
4,376
+396
+10% +$34.3K 0.05% 247
2024
Q3
$358K Sell
3,980
-79
-2% -$6.65K 0.05% 257
2024
Q2
$319K Buy
4,059
+468
+13% +$38.4K 0.05% 255
2024
Q1
$313K Buy
3,591
+41
+1% +$3.5K 0.05% 257
2023
Q4
$292K Sell
3,550
-200
-5% -$15.2K 0.06% 208
2023
Q3
$294K Hold
3,750
0.07% 207
2023
Q2
$330K Buy
3,750
+232
+7% +$20K 0.07% 208
2023
Q1
$284K Buy
3,518
+48
+1% +$3.91K 0.06% 224
2022
Q4
$270K Sell
3,470
-173
-5% -$14K 0.06% 236
2022
Q3
$294K Hold
3,643
0.07% 212
2022
Q2
$327K Hold
3,643
0.07% 210
2022
Q1
$404K Sell
3,643
-24
-0.7% -$2.54K 0.07% 197
2021
Q4
$379K Sell
3,667
-23
-0.6% -$2.66K 0.06% 208
2021
Q3
$463K Sell
3,690
-75
-2% -$9.71K 0.08% 193
2021
Q2
$467K Sell
3,765
-56
-1% -$7.03K 0.08% 193
2021
Q1
$451K Sell
3,821
-222
-5% -$26K 0.09% 202
2020
Q4
$474K Hold
4,043
0.1% 183
2020
Q3
$420K Hold
4,043
0.09% 178
2020
Q2
$371K Sell
4,043
-191
-5% -$18.3K 0.09% 183
2020
Q1
$382K Sell
4,234
-664
-14% -$70.6K 0.12% 165
2019
Q4
$556K Hold
4,898
0.14% 151
2019
Q3
$532K Sell
4,898
-200
-4% -$20.9K 0.16% 147
2019
Q2
$496K Buy
5,098
+247
+5% +$22.6K 0.14% 164
2019
Q1
$442K Sell
4,851
-10
-0.2% -$895 0.13% 165
2018
Q4
$442K Sell
4,861
-790
-14% -$73.8K 0.16% 151
2018
Q3
$556K Hold
5,651
0.13% 158
2018
Q2
$483K Sell
5,651
-11,000
-66% -$919K 0.14% 169
2018
Q1
$1.33M Sell
16,651
-3,591
-18% -$296K 0.4% 66
2017
Q4
$1.64M Sell
20,242
-1,000
-5% -$80.1K 0.54% 51
2017
Q3
$1.65M Sell
21,242
-900
-4% -$74.7K 0.56% 48
2017
Q2
$1.97M Sell
22,142
-145
-0.7% -$12.2K 0.63% 37
2017
Q1
$1.79M Sell
22,287
-673
-3% -$52.6K 0.66% 37
2016
Q4
$1.64M Sell
22,960
-3,537
-13% -$278K 0.58% 45
2016
Q3
$2.29M Buy
26,497
+64
+0.2% +$5.58K 0.81% 32
2016
Q2
$2.29M Hold
26,433
0.84% 30
2016
Q1
$1.98M Sell
26,433
-573
-2% -$43.2K 0.69% 33
2015
Q4
$2.08M Sell
27,006
-1,053
-4% -$79.3K 0.71% 31
2015
Q3
$1.88M Sell
28,059
-1,573
-5% -$116K 0.77% 30
2015
Q2
$2.2M Buy
29,632
+290
+1% +$22.2K 0.82% 23
2015
Q1
$2.29M Buy
29,342
+5,442
+23% +$412K 0.84% 24
2014
Q4
$1.73M Sell
23,900
-500
-2% -$34.7K 0.64% 37
2014
Q3
$1.51M Buy
24,400
+1,000
+4% +$63.6K 0.57% 42
2014
Q2
$1.49M Buy
23,400
+7,500
+47% +$456K 0.58% 42
2014
Q1
$978K Hold
15,900
0.41% 63
2013
Q4
$913K Hold
15,900
0.38% 69
2013
Q3
$847K Sell
15,900
-1,500
-9% -$80.7K 0.4% 67
2013
Q2
$896K Buy
+17,400
New +$860K 0.48% 60

Other funds holding MDT

Aviance Capital Partners's MDT Position: Q1 2026 in Review

Aviance Capital Partners reduced its Medtronic (MDT) stake by 0.56% in Q1 2026, selling an estimated $2.87K and leaving 5,287 shares worth $458K. The position accounts for 0.05% of the portfolio, ranked #251.

Aviance Capital Partners first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.29M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Aviance Capital Partners held 5,287 shares of Medtronic worth $458K as of Q1 2026.
  • Aviance Capital Partners sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
  • Medtronic made up 0.05% of Aviance Capital Partners's portfolio in Q1 2026, its #251 holding.
  • Aviance Capital Partners first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Aviance Capital Partners's Medtronic position peaked at $2.29M in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.